Quantcast

Latest biopharmaceutical Stories

2014-10-22 08:31:10

- Interim Results from Ongoing Study Demonstrate Human Proof-of-Concept and Underscore the Value of Regulus' microRNA Platform - LA JOLLA, Calif., Oct.

2014-10-22 08:27:12

NEW YORK, Oct. 22, 2014 /PRNewswire/ -- Provectus Biopharmaceuticals, Inc. (NYSEMKT: PVCT) specializes in developing oncology and dermatology therapies.

2014-10-20 08:32:21

Expands rHuPH20 Production SAN DIEGO, Oct. 20, 2014 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that the U.S.

2014-10-14 23:09:20

Selexis has promoted director of European business development, Marco Bocci, PhD, PharmD, to Vice President, European Licensing and Business Development for Europe. Geneva,

2014-10-07 08:30:26

IDT Biologika is among the few biopharmaceutical CMOs in Europe to offer a unique combination of sterile liquid dosage forms and vaccines contract manufacturing services LONDON, Oct.

2014-10-03 23:07:20

Learn how SAS Grid improves services to SAS users, improves performance and administration for IT, and why it is being adopted at biopharmaceutical companies and CROs worldwide. (PRWEB)

2014-10-03 16:24:22

SAN DIEGO, Oct. 3, 2014 /PRNewswire/ -- Sorrento Therapeutics, Inc.

2014-10-03 08:24:22

SAN DIEGO, Oct. 3, 2014 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that the U.S.


Word of the Day
dipsas
  • A serpent whose bite was fabled to produce intense thirst.
The word 'dipsas' comes from a Greek word meaning 'thirst'.